Company page

Protalix Biotherapeutics, Inc. (de)

Protalix Biotherapeutics, Inc. is a public company traded under the ticker PLX in the American market. The company has a market capitalization of approximately $191.76 million. Protalix focuses on developing biopharmaceuticals using its proprietary plant cell-based protein expression system.